# FDA recall D-1014-2017

> **SCA Pharmaceuticals** · Class II · drug recall initiated 2017-07-14.

## Product

fentaNYL 2 mcg/mL + BUPIvacaine 0.1% PF in 0.9% NS 250 mL, Rx only, SCA Pharmaceuticals 8821 Knoedl Ct Little Rock, AR 72205 --- NDC# 70004-0230-40

## Reason for recall

Lack of Assurance of Sterility; product has the potential to leak.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1014-2017
- **Recalling firm:** SCA Pharmaceuticals
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-07-14
- **Report date:** 2017-08-02
- **Termination date:** 2019-05-01

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Little Rock, AR, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1014-2017

## Citation

> AI Analytics. FDA recall D-1014-2017. Retrieved 2026-05-24 from https://api.ai-analytics.org/recall/D-1014-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*